SEC Form 4 · accession 0001144204-15-060223
Cytosorbents Corp · CTSO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Phillip P. Chan
Officer — President and CEO · Director
Period of report
Oct 19, 2015
Accepted (ET)
Oct 21, 2015 · 4:03 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001175151
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Oct 19, 2015 | X | 667 | $3.75 | A | 72,643 | D | |
| Common Stock | Oct 19, 2015 | X | 800 | $3.125 | A | 73,442 | D | |
| Common Stock | Oct 19, 2015 | X | 2,000 | $2.50 | A | 75,443 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Warrant (right to buy) | $3.75 | Oct 19, 2015 | X | 667 | D | Oct 22, 2012 | Oct 22, 2015 | Common Stock | 667 | 0 | D |
| Warrant (right to buy) | $3.125 | Oct 19, 2015 | X | 800 | D | Oct 22, 2012 | Oct 22, 2015 | Common Stock | 800 | 0 | D |
| Warrant (right to buy) | $2.50 | Oct 19, 2015 | X | 2,000 | D | Oct 22, 2012 | Oct 22, 2015 | Common Stock | 2,000 | 0 | D |